3mon
How to identify and treat triple-negative breast cancer — a rare but aggressive form of cancer
Triple-negative breast cancer does not respond to targeted breast cancer treatments, which limits treatment to primarily chemotherapy for now.
Impact of neoadjuvant chemotherapy on survival outcome in advanced endometrial cancer in Hispanic vs non-Hispanic women. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...
According to an international multicenter study, CD2-negative mast cells are associated with significantly reduced overall survival in patients with SM. Patients with CD2-negative mast cells have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback